

Get in the KNOW
on LA Startups & Tech
XMeet the Startup That Wants To Deliver Ketamine to Your Door
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Ketamine is on the come up in the pharmaceutical world. Once confined to nightclubs and operating rooms, the drug is quickly gaining recognition as a valuable tool for treating mental health disorders including depression and anxiety.
Amid these rising tides, Wondermed has emerged, offering telehealth consultations and, potentially, the ability to deliver the drug right to your doorstep—all while building out a virtual platform and collecting data on how to use the molecule more effectively.
At the moment, the company provides a mail order service for courses of ketamine lozenges to those who’ve been prescribed the drug along with a telehealth software bridge between doctor and patient. Wondermed currently operates in five states — California, Texas, Florida, New York and Connecticut, though it plans to expand to another eight to 10 states in the next two weeks.
In the long run however, its plans are much bigger than being a link between doctors and patients.
“We generate more than 3,000 data points on every patient that comes into the funnel, and actually receives the medication,” says co-founder & Managing Director Jose Aycart.
His company is building out its online platform to collect and analyze patient data and provide mental health support services that may be useful, regardless of whether or not a patient is taking ketamine.
These data show in granular detail how ketamine therapies work. Does the route of administration matter? Does time of day matter? What types of patients are most likely to experience positive outcomes? It’s this data that represents the biggest business opportunity for Wondermed. The specifics of the monetization are still being worked out, but Aycart says it will never sell anonymized patient data to other companies.
Wondermed is in the midst of a seed funding round, targeting $7 million by the end of the month; It’s raised $5.6 million so far.
The company makes a bit of revenue by charging patients for consultations, but in the event that a patient doesn’t wind up using Wondermed’s platform, the consultation fee is refunded. For patients who are prescribed ketamine, the company charges only as much as the drugs cost them ($249 per month, which includes four doses), so neither Wondermed nor the physicians in its employ are incentivized to over-prescribe.
The drugs themselves are supplied by Tailor Made Compounding, a pharmacy in Nicholasville, Kentucky, and Wondermed is working on additional contracts in the pipeline with several other suppliers.
. Wondermed’s transformation comes as ketamine, which has typically been restricted to use as a general anesthetic, is quickly gaining recognition as a valuable tool for treating mental health disorders like depression and anxiety.
“What I’ve found interesting is how rapidly this field has emerged,” says Steven Grant, a drug and addiction researcher who spent 25 years at the National Institute on Drug Abuse and is now retired.

Ketamine is a simple organic molecule that first gained clinical popularity in the 1960s as an anesthetic. It produces a dissociative state in patients and dulls pain. Once in the bloodstream, the molecule travels to the brain where it binds to a protein called NMDA on the surface of neurons. NMDA has a variety of jobs, but it’s best-known for its role in learning, memory, and neuroplasticity—or the brain’s ability to form new pathways between neurons.
While the research into why ketamine is such an effective treatment for depression and anxiety is ongoing, the consensus so far is that the molecule’s power comes from this ability to rewrite or rewire the brain’s circuitry. If you’ve ever had an anxiety attack or a depressive episode, it can often feel like you’re stuck in a mental loop. Ketamine, it seems, offers a way to break that loop.
“It was this idea that you're increasing your neurological connections in the brain,” says Aycart. “You have the opportunity now to spark new forms of thought, new forms of emotion, or even new ideas.”
Unlike selective serotonin reuptake inhibitors (SSRIs) and other traditional drugs used to treat depression, ketamine’s effects are fast-acting—often appearing within minutes or hours of administration—and don’t require taking the drug daily.
“It really is revolutionary, and that’s why now more than ever, people are starting to get access to it, and companies like ourselves are really trying to bring it to people as an alternative form of medicine,” says Aycart.
Grant says the rise of ketamine clinics and telehealth services like Wondermed are likely a net positive because they increase patient access to drugs patients need, but he also has reservations about how the therapies are being applied.
Many of these psychoactive drugs—especially ketamine—are intended to be used in tandem with therapy, or at least under the supervision of a trained professional. Increasing the brain’s plasticity is a valuable tool for breaking out of depressive loops, but unless a professional is there to help the patient settle into a healthier mental pattern, the full benefits may be left on the table.
Wondermed offers a variety of supplementary support and strategies along with the drugs themselves, but taking advantage of these tools is left to the patient’s discretion. Grant would like to see a larger focus on extending and expanding that auxiliary support.
The company says it’s focused on building out the platform’s nonmedicinal mental health strategies—things like breathwork, meditation, music therapy—and adding them to an app. If they can get enough people on board, the eventual plan could be to sell health insights back to patients through a subscription model or something similar. They may even patent their own psychedelic molecules in the future. But all of this is likely quite a ways out.
“What we're trying to do is very new, and the landscape yet hasn't been built out,” says Aycart.
Clarification: This story has been updated to clarify Wondermed's monthly rate for ketamine lozenges.
From Your Site Articles
- Psychedelic Therapies Are Gaining Steam as Attitudes Change - dot ... ›
- Ketamine for Depression Is Now Available by Injection - dot.LA ›
- Ketamine Clinics Are Opening Across Los Angeles - dot.LA ›
- Pasithea Opens a Chic Clinic in Beverly Hills to Administer Ketamine - dot.LA ›
- New Pasithea Ketamine Clinic In Beverly Hills - dot.LA ›
- Pasithea Opens a Ketamine Clinic In Beverly Hills - dot.LA ›
Related Articles Around the Web
David Shultz
David Shultz reports on clean technology and electric vehicles, among other industries, for dot.LA. His writing has appeared in The Atlantic, Outside, Nautilus and many other publications.
Behind Her Empire: How Camping World CEO Marcus Lemonis Lives Out His 'Mother's Mission'
04:08 PM | July 23, 2021
Marcus Lemonis
On this episode of the Behind Her Empire podcast, hear from Marcus Lemonis, the CEO and chairman of the multi-billion dollar business Camping World and the host of CNBC's "The Profit."
Lemonis is the first male guest on Behind Her Empire, but prioritizing diverse entrepreneurship remains the theme for this episode. Lemonis says he is constantly inspired by his mother who "always felt… that women rule the world."
He says he's made his mother's values a cornerstone in his work, which is centered around "living out my mother's mission." To Lemonis, this means "creating platforms and creating pathways that allow women and women of color and people of color… to be given opportunities that have been… not made available to them."
To achieve this, he created The Lemon-AID Foundation, focused on backing underrepresented founders, which he seeded with $50 million of his own money.
Lemonis says he prefers to work with female founders because he "think[s] that women, generally speaking, don't make decisions with their ego." He also shares how he thinks "women make better business people because they also manage with a level of empathy."
Lemonis also shares his strategies for overcoming the fear of embarrassment, something he feels everyone has to deal with. He argues that by giving yourself permission to be embarrassed, you give yourself permission to fail, and fail with dignity.
In the rest of the conversation, Marcus shares how he got started with entrepreneurship, how he avoids imposter syndrome and how he dresses to feel free.
Marcus Lemonis is the CEO and chairman of Camping World, and the host of "The Profit."
"Ultimately, businesses are run by people... Whether you're running Dell computers, or Susie's coffee shop, the numbers may have more commas in them. But it really doesn't change the principles." —Marcus Lemonis
dot.LA Engagement Intern Colleen Tufts contributed to this post.
Want to hear more of the Behind Her Empire podcast? Subscribe on Stitcher, Apple Podcasts, Spotify, iHeart Radio or wherever you get your podcasts.
From Your Site Articles
Related Articles Around the Web
Read moreShow less
Yasmin Nouri
Yasmin is the host of the "Behind Her Empire" podcast, focused on highlighting self-made women leaders and entrepreneurs and how they tackle their career, money, family and life.
Each episode covers their unique hero's journey and what it really takes to build an empire with key lessons learned along the way. The goal of the series is to empower you to see what's possible & inspire you to create financial freedom in your own life.
💘Zeitview’s New Valentine : Catching Methane Leaks
10:20 AM | February 13, 2026
🔦 Spotlight
Hello Los Angeles, happy Friday and happy Valentine’s Day weekend.
While the rest of us are debating flowers vs. gifts vs. reservations, LA’s infrastructure nerds are out here celebrating a different kind of romance: finding leaks before they ghost your entire operation.
Zeitview just made methane a first-class feature
Zeitview has acquired Insight M, folding high-frequency aerial methane detection into its broader “see it, measure it, fix it” play for critical infrastructure. The combined offering pairs methane monitoring with Zeitview’s predictive asset-health and inspection workflows, so operators can spot emissions faster, prioritize repairs, and tie results back to ROI instead of vibes.
What Zeitview actually does, beyond the buzzwords
If you haven’t been tracking them, Zeitview is essentially the operating layer for inspecting big, physical assets using drones, aircraft, and computer vision. They can analyze imagery you already have or capture fresh data, then turn it into inspection reports and analytics through their Asset Insights platform.
Zeitview was previously known as DroneBase and rebranded after raising an expansion round, signaling a broader push beyond “drones” into enterprise-grade infrastructure intelligence across energy and other asset-heavy industries.
Why Insight M fits, and why this isn’t just “climate tech”
Methane is the rare climate problem that also hits the P&L, because a leak is both emissions and lost product. Insight M has built credibility around methane monitoring that’s meant to be operational, not just observational, and that plugs neatly into Zeitview’s inspection footprint.
Put together, this looks less like a single acquisition and more like a workflow upgrade: one system that finds a problem, quantifies it, routes it to the right team, and proves it was fixed. The least romantic Valentine’s message of all, maybe, but also the most adult: “I noticed something small, and I handled it before it became expensive.”
Keep scrolling for the latest LA venture rounds, fund news and acquisitions.
🤝 Venture Deals
LA Companies
- HAWKs (Hiking Adventures With Kids), a nature-based children’s enrichment brand founded in Los Angeles, secured a strategic investment from Post Investment Group to accelerate its nationwide franchise expansion. The company plans to scale its mobile, outdoor-program model (after-school adventures, camps, and weekend sessions) by opening franchise territories across the U.S. while using Post’s franchising platform to build the operational infrastructure and support system for new operators. - learn more
LA Venture Funds
- Allomer Capital Group participated in TRUCE Software’s newly closed Series B, a round led by Yttrium with additional backing from New Amsterdam Growth Capital. The company did not disclose the amount, but says it will use the funding to scale go-to-market for two mobile-first product suites: an AI video telematics platform for commercial fleets that runs on standard smartphones, and TRUCE Family, a software approach to limiting student phone distractions in K–12 schools. - learn more
- Wonder Ventures participated in The Biological Computing Company’s $25M seed round, which was led by Primary Venture Partners alongside Builders VC, Refactor Capital, E1 Ventures, Proximity, and Tusk Ventures. The startup is commercializing “biological compute,” connecting living neurons to modern AI systems to make certain tasks dramatically more energy-efficient, and says its first product shows a 23x retained improvement in video model efficiency while also helping discover new AI architectures. - learn more
- Bonfire Ventures co-led Santé’s $7.6M seed round, with backing from Operator Collective, Y Combinator, and Veridical Ventures. Santé is building an AI- and fintech-driven operating system for wine and liquor retailers that brings POS, inventory, e-commerce, delivery orders, and invoice workflows into one platform to replace a lot of manual, fragmented processes. - learn more
- B Capital co-led Apptronik’s initial 2025 Series A and participated again in the company’s new $520M Series A extension, bringing the total Series A to $935M+ (nearly $1B raised overall). The company says it will use the fresh capital to ramp production and deployments of its Apollo humanoid robots and invest in facilities for robot training and data collection, with the extension also bringing in new backers like AT&T Ventures, John Deere, and Qatar Investment Authority alongside repeat investors including Google and Mercedes-Benz. - learn more
- WndrCo participated in Inertia Enterprises’s new $450M Series A, a round led by Bessemer Venture Partners with additional investors including GV, Modern Capital, and Threshold Ventures. The company says it will use the milestone-based financing to commercialize laser-based fusion built on physics proven at the National Ignition Facility at Lawrence Livermore National Laboratory, including building its “Thunderwall” high-power laser system and scaling a production line to mass-manufacture fusion fuel targets. - learn more
- Riot Ventures participated as a returning investor in Integrate’s $17M Series A, which was led by FPV Ventures with participation from Fuse VC and Rsquared VC. Integrate is pitching an ultra-secure project management platform built for classified, multi-organization programs, and says it has become a requirement for certain U.S. Space Force launch efforts. The company plans to use the new funding to ship additional capabilities for government customers and scale go-to-market across the defense tech sector. - learn more
- MANTIS Ventures participated in Project Omega’s $12M oversubscribed seed round, which was led by Starship Ventures alongside Buckley Ventures, Decisive Point, Slow Ventures, and others. Project Omega is emerging from stealth to build an end-to-end nuclear fuel recycling capability in the U.S., aiming to turn spent nuclear fuel into long-duration power sources and critical materials, with early lab demonstrations underway and an ARPA-E partnership to validate a commercially viable recycling pathway. - learn more
- Plus Capital participated in Garner Health’s $118M round, which was led by Khosla Ventures with additional backing from Founders Fund and existing investors including Maverick Ventures and Thrive Capital, valuing the company at $1.35B. Garner says it helps employers steer members to high-quality doctors using its “Smart Match” provider recommendations and a reimbursement-style incentive called “Garner Rewards,” and it will use the funding to expand its offerings, grow its care team, and scale partnerships with payers and health systems. - learn more
- Emerging Ventures co-led Taiv’s $13M Series A+ alongside IDC Ventures, with continued support from investors including Y Combinator and Garage Capital. Taiv says it will use the funding to scale its “Business TV” platform, which uses AI to detect and swap TV commercials in venues like bars and restaurants with more relevant ads and on-screen content, as it expands across major North American markets. - learn more
LA Exits
- Mattel163 is being acquired by Mattel, which is buying out NetEase’s remaining 50% stake and valuing the mobile games studio at $318M. The deal gives Mattel full ownership and control of the team behind its IP driven mobile titles, strengthening its in-house publishing and user acquisition capabilities as it expands its digital games business. - learn more
- DJ Mex Corp. is set to be acquired in part by Marwynn Holdings, which signed a non-binding letter of intent to purchase a 51% stake in the U.S.-based e-waste sourcing and logistics company. The deal would bring DJ Mex into Marwynn’s EcoLoopX platform to expand its asset-light “reverse supply chain” services for recyclable materials, though it’s still subject to due diligence and final agreements. - learn more
Read moreShow less
RELATEDTRENDING
LA TECH JOBS


